CSGP4 IgE exerted direct effects against melanoma cells compared to non-specific IgE and engaged human healthy volunteer and melanoma patient-derived effector cells to trigger in vitro effector functions, tumor cell cytotoxicity and degranulation. The gene discussed is IGHE; the disease is melanoma.